Investor Relations

Latest News

View Press Release
View All News

Latest Financial Results

Q3 2020

Quarter Ended Sep 30, 2020
10-Q Filing
PDF HTML
XBRL
ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Report Links

Company Overview

H-CYTE is a medical biosciences company focused in the field of regenerative medicine. H-CYTE’s mission is to become a leader in next-generation, cellular therapeutics for the treatment of chronic health conditions. 

Investor Contact Information

Company

H-CYTE, Inc
201 E Kennedy Blvd
Suite 700
Tampa, FL 33602

Investor Relations

LR Advisors LLC
Jason Assad
President
2020 Stone Meadow Way
Cumming, GA 30041
T: (678) 570-6791
jassad@HCYTE.com

Transfer Agent

Interwest Transfer Co., Inc.
1981 Murray Holiday Rd
Ste 100
Salt Lake City, UT 84117
T: (801) 272-9294

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.